Product Information
ALREX 0.2% EYE DROPS is a brand product labeled by Bausch & Lomb Incorporated, priced at $57.9936 per ML under NDC 24208035310. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208035310
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA020803On Market Since
3/9/1998
Pharmacological Classes
Price Statistics
The NADAC for ALREX 0.2% EYE DROPS has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 111.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.9936 per ML |
|---|---|
| All-time high | $58.2584 (May 14, 2025) |
| All-time low | $27.3930 (Nov 28, 2013) |
| 52-week high | $58.1209 |
| 52-week low | $57.8963 |
| Median price | $45.6497 |
| Average price | $44.9305 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALREX 0.2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ALREX 0.2% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $57.9936 per ML (NDC 24208035310), effective Jun 24, 2026.
How has the price of ALREX 0.2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ALREX 0.2% EYE DROPS has risen 111.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALREX 0.2% EYE DROPS?
Since Nov 28, 2013, the NADAC for ALREX 0.2% EYE DROPS has ranged from a low of $27.3930 (Nov 28, 2013) to a high of $58.2584 (May 14, 2025), with a median of $45.6497 per ML.
Are there cheaper alternatives to ALREX 0.2% EYE DROPS?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LOTEPREDNOL ETABONATE 0.2% DRP, is $30.6020 per ML — about 47% below ALREX 0.2% EYE DROPS.
Who manufactures ALREX 0.2% EYE DROPS?
ALREX 0.2% EYE DROPS (NDC 24208035310) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.
Related Drugs
Same classification